Spectrum of Anxiety Disorders: Diagnosis and Pharmacologic Treatment

Journal of Midwifery and Women's Health

Volumn 56, Issue 3, 2011, Pages 266-281

  Karsnitz, Deborah Brandt ^a   Ward, Sheila ^a  

^a NONE   (United States)

Author keywords

Anxiety disorders; Breastfeeding; Generalized anxiety disorder; Obsessive compulsive disorder; Panic disorder; Posttraumatic stress disorder; Pregnancy

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; ESCITALOPRAM; FLUOXETINE; INOSITOL; KAVA; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; OMEGA 3 FATTY ACID; PAROXETINE; PLACEBO; PROPRANOLOL; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ACUTE STRESS DISORDER; AGITATION; ALTERNATIVE MEDICINE; ANXIETY DISORDER; APGAR SCORE; BLEEDING; BLURRED VISION; BRADYCARDIA; BRONCHOSPASM; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DOSE RESPONSE; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; FATIGUE; FETUS MOVEMENT; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HEADACHE; HUMAN; HYPERTENSION; HYPONATREMIA; HYPOTENSION; INSOMNIA; IRRITABILITY; LIBIDO DISORDER; LOW BIRTH WEIGHT; LOW DRUG DOSE; MORNING DOSAGE; MUSCLE HYPOTONIA; NAUSEA; NEWBORN DISEASE; OBSESSIVE COMPULSIVE DISORDER; OFF LABEL DRUG USE; ORGASM DISORDER; PANIC; PATIENT COMPLIANCE; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PREGNANCY OUTCOME; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PULMONARY HYPERTENSION; RASH; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN BRUISING; SLEEP DISORDER; SLEEP INDUCTION; SOCIAL PHOBIA; SWEATING; TREMOR; UNSPECIFIED SIDE EFFECT; VIVID DREAM; VOMITING; WEAKNESS; WEIGHT GAIN; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; BENZODIAZEPINES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 79955509579     PISSN: 15269523     EISSN: 15422011     Source Type: Journal    
DOI: 10.1111/j.1542-2011.2011.00045.x     Document Type: Review

References (83)

1. Statistics. National Institute of Mental Health. Updated August 6, 2010. Accessed July 15, 2010.
2. World Health Organization. Global Burden of Disease: 2004 update. Accessed July 15, 2010.
3. World Health Organization. Web site. Burden of mental and behavioural health. Chapter 2. Accessed March 2, 2010.
4. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602.
5. Seedat S, Scott KM, Angermeyer MC, et al Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry. 2009;66(7):785-795.
6. Howell HB, Brawman-Mintzer O, Monnier J, Yonkers KA. Generalized anxiety disorder in women. Psychiatr Clin North Am. 2001;24(1):165-178.
7. Kroenke K, Spitzer RL, Williams JB, Monahan P, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317-325.
8. Pigott TA. Anxiety disorders in women. Psychiatr Clin North Am. 2003;26:621-672.
9. Roy-Byrne PP, Davidson KW, Kessler RC, et al Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30:208-225.
10. Moffitt TE, Harrington BA, Avshalom C, et al Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry. 2007;64:651-660.
11. Zender R. Olshansky E. Women's mental health: depression and anxiety. Nurs Clin N Am. 2009;44:355-364.
12. Olatunji BO, Cisler JM, Deacon BJ. Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings. Psychiatr Clin North Am. 2010;33(3):557-577.
13. Tolin DF. Is cognitive-behavioral therapy more effective than other therapies? a meta-analytic review. Clin Psychol Rev. 2010;30(6):710-720.
14. Katon WJ. Panic disorder. N Engl J Med. 2006;354(22):2360-2367.
15. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63.
16. Feeny NC, Zoellner LA, Kanana SY. Providing a treatment rationale for PTSD: Does what we say matter? Behav Res Ther. 2009;47:752-760.
17. Weisberg RB, Dyck I, Culpepper L, Keller MB. Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists. Am J Psychiatry. 2007;164:276-282.
18. Esselman P, Berbrayer D, Friedly J, Granger C, Mayer RS. Chronic care education in medical school: a focus on functional health and quality of life. Am J Phys Med Rehabil. 2009;88(10):798-804.
19. Frieder A, Dunlop AL, Culpepper L, Bernstein, PS. The clinical content of preconception care: women with psychiatric conditions. Am J Obstet Gynecol. 2008:S328-S332.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision (DSMV-IV-TR). Washington, DC American Psychiatric Association; 2000.
21. Vesga-Lopez O, Schneier FR, Wang S, et al Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2008;69(10):1606-1616.
22. Davidson JR, Zhang W, Connor KM, et al A psychopharmacological treatment algorithm for generalized anxiety disorder (GAD). J Psychopharmacol. 2010;24(1):3-26.
23. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147-155.
24. Katzman MA. Current considerations in the treatment of generalized anxiety disorder. CNS Drugs. 2009;23(2):103-120.
25. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.
26. van Bussel JCH, Spitz B, Demyttenaere K. Anxiety in pregnant and postpartum women: an exploratory study of the role of maternal orientations. J Affect Disord. 2009;114:232-242.
27. Alder J, Fink N, Bitzer J, Hosli I, Holzgreve W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med. 2007;20(3):189-209.
28. Strohle A, Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry. 2003;36:S207-S214.
29. van Batenburg-Eddes T, de Groot L, Huizink AC, et al Maternal symptoms of anxiety during pregnancy affect infant neuromotor development: the Generation R study. Dev Neuropsychol. 2009;34(4):476-493.
30. Vythilingum B. Anxiety disorders in pregnancy. Curr Psychiatry Rep. 2008;01:331-335.
31. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782-786.
32. Beck CT, Gable RK. Further validation of the Postpartum Depression Screening Scale. Nurs Res. 2001;50(3):155-164.
33. Kapczinski FFK, Silva de Lima M, dos Santos Souza JJSS, Batista Miralha da Cunha AABC, Schmitt RRS. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev 2003;(2):CD003592. doi.
34. Sheehan DV, Keene MS, Eaddy M, Krulewicz S, Kraus JE, Carpenter DJ. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. CNS Drugs. 2008;22(11):963-973.
35. Bose A, Korotzer A, Gommoll C, Dayong L. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. Depress Anxiety. 2008;25:854-861.
36. Nestadt G. Obsessive-compulsive disorder issues pertinent to women. Women's Health. 2008;4(4):311-313.
37. Fineberg N, Fourie H, Gale T, Sivakumaran T. Comorbid depression in obsessive compulsive disorder (OCD): symptomatic differences to major depressive disorder. J Affect Disord. 2005;87(2):327-330.
38. Uguz F, Gezginc K, Zeytinci IE, et al Obsessive-compulsive disorder in pregnant women during the third trimester of pregnancy. Compr Psychiatry. 2007;48:441-445.
39. Zambaldi CF, Cantilino A, Montenegro AC, Paes JA. Postpartum obsessive-compulsive disorder: prevalence and clinical characteristics. Compr Psychiatry. 2009;50(6):503-509.
40. Gangdev P. The relationship between obsessive-compulsive disorder and psychosis. Australas Psychiatry. 2002;10(4):405-410.
41. Rabinowitz I, Baruch Y, Barak Y. High-dose escitalopram for the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 2008;23:49-53.
42. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627.
43. National Institute of Mental Health. The numbers count: mental disorders in America. 2009. Accessed March 15, 2010.
44. Meshberg-Cohen S, Svikis D. Panic disorder, trait anxiety, and alcohol use in pregnant and nonpregnant women. Compr Psychiatry. 2007;48:504-510.
45. Indman P, Bennett S. Beyond the Blues: Prenatal and Postpartum Depression, A Treatment Manual 2006. San Jose, CA Moodswings Press.
46. Goodwin R, Lewinsohn P, Seeley J. Cigarette smoking and panic attacks among young adults in the community: the role of parental smoking and anxiety disorders. Biol Psychiatry. 2005;58(9):686-693.
47. Zvolensky MJ, Leen-Feldner EW, Feldner MT, et al Emotional responding to biological challenge as a function of panic disorder and smoking. J Anxiety Disord. 2008;18(1):19-32.
48. Maxmen JS, Ward NG. Essential Psychopathology and its Treatment. 2nd ed. New York WW Norton & Co; 1986:252.
49. Rambelli C, Montagnani MS, Oppo A, et al Panic disorder as a risk factor for post-partum depression: results from the Perinatal Depression-Research & Screening Unit (PND-ReScU) study. J Affect Disord. 2010;122:139-143.
50. Ham P, Waters DB, Oliver MN. Treatment of panic disorder. Am Fam Physician. 2005;71:733-740.
51. Zaers S, Waschke M, Ehlert U. Depressive symptoms and symptoms of post-traumatic stress disorder in women after childbirth. J Psychosom Obstet Gynaecol. 2008;29(1):67-71.
52. Smith MV, Poschman K, Cavaleri MA, Howell HB, Yonkers KA. Symptoms of posttraumatic stress disorder in a community sample of low-income pregnant women. Am J Psychiatry. 2006;163:881-884.
53. Loveland Cook CA, Flick LH, Homan SM, Campbell C, McSweeney M, Gallagher ME. Posttraumatic stress disorder in pregnancy: prevalence, risk factors, and treatment. Obstet Gynecol. 2004;103(4):710-717.
54. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol. 1993;61:984-991.
55. Fisher B, Cullen F, Turner M. The Sexual Victimization of College Women. Washington, DC National Institute of Justice and Bureau of Justice Statistics.
56. Wang PS, Berglund P, Olfson M, Pincus HA Wells KB, Kessler RC. Failure and delay initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:603-613.
57. Beck CT. The anniversary of birth trauma: failure to rescue. Nurs Res. 2006;55(6):381-390.
58. Shaley A. Posttraumatic stress disorder and stress-related disorders. Psychiatr Clin North Am. 2009;32(3):687-704.
59. Creedy DK, Shochet IM, Horsfall J. Childbirth and the development of acute trauma symptoms: incidence and contributing factors. Birth. 2000;27(2):104-111.
60. Rogal S, Poschman K, Belanger K, et al Effects of posttraumatic stress disorder on pregnancy outcomes. J Affect Disord. 2007;102(1):137-143.
61. Morland L, Goebert D, Onoye J, et al Posttraumatic stress disorder and pregnancy health: preliminary update and implications. Psychosomatics. 2007;48(4):304-308.
62. Ayers S, Eagle A, Waring H. The effects of childbirth-related post-traumatic stress disorder on women and their relationships: a qualitative study. Psychol Health Med. 2006;11(4):389-398.
63. Holzman C, Senagore P, Tian Y, et al Maternal catecholamine levels in midpregnancy and risk of preterm delivery. Am J Epidemiol. 2009;170(8):1014-1024.
64. Brady K, Pearlstein T, Asnis GM, et al Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283:1837-1844.
65. Davidson JRT, Rothbaum BO, Van Der Kolk B, Sikes CR, Farfel GM. Multicenter, double blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485-492.
66. King T, Johnson R, Gamblian V. Mental health. In King TL, Brucker MC, eds. Pharmacology for Women's Health. Sudbury, MA Jones and Bartlett; 2010:750-791.
67. Stein DJ, Ipser J, McAnda N. Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines. CNS Spectr. 2009;14(1)(suppl 1):25-31.
68. Yeager D, Smith HG, Altshuler L. Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum. Am J Psychiatry. 2006;163(12):2064-2070, 2068.
69. Stahl SM. Essential psychopharmacology online; 2008. Accessed August 31, 2010.
70. Alwan E, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007;356(26):2684-2692.
71. Simoncelli M, Martin BZ, Berard A. Antidepressant use during pregnancy: a critical systematic review of the literature. Curr Drug Safety. 2010;5(2):153-170.
72. Hackley B. Antidepressant medication use in pregnancy. J Midwifery Womens Health. 2010;55(2):90-100.
73. ACOG Practice Bulletin. Use of psychiatric medications during pregnancy and lactation: clinical management guidelines for obstetrician-gynecologists, number 92. Obstet Gynecol. 2008;111:1001-1020.
74. Hale T. Medications and Mothers' Milk, 13th ed. Amarillo, TX Hale Publishing; 2008.
75. Andrade WE, Raebel MA, Brown J, et al Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198:194.e1-e5.
76. Johnson R. Mental illness in primary women's health care. In: Hackley B, Kriebs JM, Rousseau ME, eds. Primary Care of Women: A Guide for Midwives and Women's Health Providers. Sudbury, MA Jones and Bartlett; 2007:249-312.
77. Edersheim JG. Off-label prescribing: minimizing risks and liabilities. Psychiatr Times. 2009;26(4):12-16.
78. Khouzam HR. Anxiety disorders: guidelines for effective primary care, Part 2, treatment. Consultant. 2009;49(4):1-3.
79. Krautkramer CJ. Case in Health Law: Neurontin and off-label marketing. Virtual Mentor. 2006;8(6):397-402. Accessed March 28, 2010.
80. Medline Plus [Internet]. Bethesda, MD National Library of Medicine (US); Herbs and supplements. Updated 2010. Accessed August 1, 2010.
81. Kendall-Tackett KA, Hale TW. Medication use for trauma symptoms and PTSD in pregnant and breastfeeding women. Trauma Psychology Newsletter. 2009;4(2):12-15.
82. Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety. Anxiety. 2007;27(3):263-272.
83. Morgan C, Krystal J, Southwick S. Toward early pharmacological posttraumatic stress intervention. Biol Psychiatry. 2003;53:835-843.